Sign In
Buy NVZMY
$65.04
-0.650 (-0.99%)
At Close: Jul 31, 2026
Novozymes A/S (NVZMF) 1H 2023 Earnings Call Transcript
02:05pm, Wednesday, 09'th Aug 2023
Novozymes A/S (OTCPK:NVZMF) 1H 2023 Earnings Conference Call August 9, 2023 3:00 AM ET Company Participants Tobias Bjorklund - Head of investor relations Ester Baiget - President and CEO Lars Green -
International Wide-Moat Stocks On Sale - The August 2023 Heat Map
12:36am, Wednesday, 09'th Aug 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of th
AXTA vs. NVZMY: Which Stock Should Value Investors Buy Now?
01:19pm, Wednesday, 12'th Jul 2023
Investors looking for stocks in the Chemical - Specialty sector might want to consider either Axalta Coating Systems (AXTA) or Novozymes A/S (NVZMY). But which of these two stocks presents investors w
International Wide-Moat Stocks On Sale - The July 2023 Heat Map
11:07am, Friday, 07'th Jul 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of th
PPG or NVZMY: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 26'th Jun 2023
Investors interested in Chemical - Specialty stocks are likely familiar with PPG Industries (PPG) and Novozymes A/S (NVZMY). But which of these two companies is the best option for those looking for u
LIN vs. NVZMY: Which Stock Is the Better Value Option?
12:42pm, Friday, 09'th Jun 2023
Investors interested in stocks from the Chemical - Specialty sector have probably already heard of Linde (LIN) and Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better
International Wide-Moat Stocks On Sale - The May 2023 Heat Map
11:17pm, Tuesday, 09'th May 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
AXTA or NVZMY: Which Is the Better Value Stock Right Now?
01:01pm, Tuesday, 09'th May 2023
Investors with an interest in Chemical - Specialty stocks have likely encountered both Axalta Coating Systems (AXTA) and Novozymes A/S (NVZMY). But which of these two stocks presents investors with th
PPG or NVZMY: Which Is the Better Value Stock Right Now?
12:57pm, Thursday, 20'th Apr 2023
Investors looking for stocks in the Chemical - Specialty sector might want to consider either PPG Industries (PPG) or Novozymes A/S (NVZMY). But which of these two stocks offers value investors a bett
International Wide-Moat Stocks On Sale - The April 2023 Heat Map
02:16am, Saturday, 08'th Apr 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
AXTA or NVZMY: Which Is the Better Value Stock Right Now?
12:56pm, Tuesday, 04'th Apr 2023
AXTA vs. NVZMY: Which Stock Is the Better Value Option?
International Wide-Moat Stocks On Sale - The March 2023 Heat Map
12:56am, Wednesday, 08'th Mar 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
Novozymes A/S (NVZMF) Q4 2022 Earnings Call Transcript
10:33pm, Thursday, 26'th Jan 2023
Novozymes A/S (OTCPK:NVZMF) Q4 2022 Earnings Conference Call January 26, 2023 3:00 AM ET Company Participants Tobias Bjorklund - Head of Investor Relations Ester Baiget - President and CEO Lars Green
Novozymes: Wonderful Company, Almost Reasonable Price
07:33pm, Monday, 23'rd Jan 2023
Novozymes is a Danish company that produces industrial enzymes, often used to replace chemicals in products and industrial processes. The company's products have a wide range of applications in househ
International Wide-Moat Stocks On Sale - The January 2023 Heat Map
10:48pm, Thursday, 05'th Jan 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
